New school for Biomedicine and Cancer Research at Tel Aviv University

Written on |

The school, funded by a generous endowment from the Shmunis Family, aims to research and improve treatments for cancer, COVID-19 and other diseases

Israel’s Minister of Science and Technology Yizhar Shay and TAU President Prof. Ariel Porat will attend the inauguration ceremony of the Shmunis School of Biomedicine and Cancer Research, to be held on Wednesday, August 12, 2020.

The School belongs to the George S. Faculty of Life Sciences and the generous donation will enable a leap in groundbreaking research. At the Shmunis School researchers will be able to identify mechanisms that drive cancer and other diseases, developing new pharmaceuticals and improving patients’ quality of life. This will be achieved through multidisciplinary collaborations and novel research approaches, such as single cell sequencing, proteomics, lipidomics and bioinformatics.

In addition, the new partnership will enable the University to recruit the finest researchers into its faculty, attract the best post-doctoral candidates, award the annual Shmunis Fellowships to exceptional PhD students, and more. The School will also collaborate with many leading academic institutions and host Shmunis Visiting Scholars and international conferences.

Create an important impact

Yizhar Shai, Israel’s Minister of Science and Technology: ”Tel Aviv University is one of the leading academic institutions in Israel and the inauguration of the Shmunis School of Biomedicine and Cancer Research proves that the university also made an international name for itself. Connections like that, between the academia and industry’s needs, create an important impact on academic institutions, the students passing through them, and the whole Israeli economy. I congratulate the Shmunis family for the most welcome donation which promotes cancer research. I have no doubt that the research and the developments from this institution will be Israel’s pride and joy.”

Prof. Ariel Porat, President of TAU: “I am grateful to the Shmunis family for their important and generous gift. The funds will enable researchers at the School to work at the forefront of global science and to develop insights leading to the development of new technologies and drugs in the battle against cancer and other serious diseases.”

Vlad and Sana Shmunis expressed the hope that the gift will help strengthen Israel’s standing as a global leader in cancer and molecular biomedical research. Vlad Shmunis: “My wife Sana and I are very happy that we can take part in supporting frontline research. Cancer is a disease that has unfortunately touched our family and far too many other families around the world.  We hope that our gift to TAU will significantly advance research and treatment of cancer and other serious diseases to improve the lives of people in Israel and around the world.”

Featured image: TAU President Prof. Ariel Porat and Israel’s Minister of Science and Technology Izhar Shay (Photo Credit: Chen Galili)

Related posts

Hyperbaric Treatment More Effective than Medicines for Fibromyalgia Caused by Head Injury

24 March 2023

Promoting Women in Medicine

9 March 2023

#TAU_WOMEN_POWER

7 March 2023

Researchers Discover Mechanism that Facilitates Formation of Brain Metastases

27 February 2023

Light Pollution is Killing Desert Rodents

10 February 2023

Three Tel Aviv University Researchers Awarded the ERC Proof of Concept (PoC) grants

9 February 2023

Researchers Identify A New Genetic Risk Factor for Age-related Eye Disease

8 February 2023

People With Autism Experience Pain at a Higher Intensity

31 January 2023

Researchers Uncover New Factors Linked to Williams Syndrome

24 January 2023

Lessons in Tolerance and DNA Extraction in Tel Aviv University’s Medical Labs

18 January 2023

Medical Clowns – No Laughing Matter

18 January 2023

Tel Aviv University’s First MedTech Hackathon Sets a High Bar

15 January 2023

Researchers use Smartwatches to Measure Safety of COVID Vaccine

28 December 2022

Tel Aviv University Establishes Multidisciplinary Center for Research of Autoimmune Diseases

18 December 2022

Breakthrough in the Field of Controlled Drug Delivery

16 December 2022

Common Medications May Reduce Risk of Metastases after Colon and Rectal Cancer

9 December 2022

Victoria

Tok Corporate Centre, Level 1,
459 Toorak Road, Toorak VIC 3142
Phone: +61 3 9296 2065
Email: office@aftau.asn.au

New South Wales

Level 22, Westfield Tower 2, 101 Grafton Street, Bondi Junction NSW 2022
Phone: +61 418 465 556
Email: davidsolomon@aftau.org.au

Western Australia

P O Box 36, Claremont,
WA  6010
Phone: :+61 411 223 550
Email: clivedonner@thelinqgroup.com